⚠️ Toxic Shock Syndrome (TSS) is NOT restricted to tampon use in menstruating females.
It can occur from even a seemingly minor wound infection, surgical site, or skin/soft-tissue infection in healthy individuals of any age or sex.

🔴 Key warning signs: Hypotension, high fever, diffuse macular erythroderma (sunburn-like rash), vomiting/diarrhoea, myalgias, and later desquamation (palms/soles).
Causative toxin = TSST-1 exotoxin (or staphylococcal enterotoxins) from Staphylococcus aureus, acting as a superantigen causing massive cytokine release.

👉 Spot it early, remove source immediately, and start toxin-suppressing antibiotics + aggressive supportive care. Mortality can exceed 5–10% if delayed.

🦠 Type of Infection	📖 Description	💊 Management (2026 Evidence-Based)
Staphylococcal Skin & Soft-Tissue Infections (SSTI)	Boils (furuncles), carbuncles, impetigo, cellulitis, abscesses, and wound infections. Most common presentation; often community-acquired MRSA in USA. Can progress to deeper infection if untreated.	🧴 Topical: Mupirocin for localized impetigo (IDSA SSTI 2014). 💊 Oral antibiotics: Dicloxacillin or cephalexin (MSSA); clindamycin, TMP-SMX, or doxycycline if MRSA suspected (IDSA MRSA 2011). ✂️ Incision & drainage (I&D): Mainstay for all abscesses >5 cm or fluctuant lesions. 🧼 Hygiene: Daily handwashing, wound care, decolonization (mupirocin nasal + chlorhexidine baths) for recurrent cases.
Staphylococcal Bacteremia	S. aureus in bloodstream → high risk of sepsis, endocarditis, osteomyelitis, septic emboli. MSSA vs MRSA distinction critical (2025 IDSA MSSA Bacteremia Measure Set).	💉 IV antibiotics: Vancomycin or daptomycin (MRSA); nafcillin/oxacillin or cefazolin (MSSA) — β-lactam preferred for MSSA (IDSA 2025 Measures). 🩺 Source control: Remove infected catheters, drain abscesses; echocardiography (TEE preferred) in all cases. 🔄 Monitor: Repeat blood cultures every 48–72 h until negative; treat 2–6 weeks depending on complications.
Staphylococcal Endocarditis	Infection of native or prosthetic heart valves 💔. Common in IV drug users, prosthetic valves, or after bacteremia. High morbidity (20–40% mortality).	💉 IV antibiotics (4–6 weeks): High-dose vancomycin/daptomycin (MRSA); nafcillin/oxacillin (MSSA) (AHA 2015 + ongoing 2026 updates). 🪡 Surgery: Valve replacement/repair if heart failure, large vegetation (>10 mm), abscess, or persistent bacteremia. 💊 Supportive care: Multidisciplinary endocarditis team; treat complications (emboli, heart failure).
Staphylococcal Osteomyelitis	Bone infection via hematogenous spread or direct inoculation (trauma/surgery). Can become chronic with sequestra if not fully debrided.	💉 IV antibiotics (4–6 weeks minimum): Vancomycin/daptomycin (MRSA); nafcillin/cefazolin (MSSA) (IDSA MRSA 2011 & pediatric AHO 2021). 🪚 Surgical debridement: Essential — remove necrotic bone and hardware. 💊 Chronic cases: Long-term oral suppression (e.g., TMP-SMX + rifampin) after initial IV course.
Staphylococcal Toxic Shock Syndrome (TSS)	Rare but life-threatening toxin-mediated illness. Classic tampon association, but also post-surgical wounds, skin infections, or nasal packing. Superantigen-driven cytokine storm.	💉 IV antibiotics: Clindamycin (toxin suppression) + vancomycin/nafcillin (IDSA & CDC recommendations). 💧 Supportive care: Aggressive IV fluids, vasopressors, ICU monitoring for multi-organ failure. ⚔️ Source control: Immediate removal of tampon/foreign body + surgical debridement of any infected site.
Staphylococcal Food Poisoning	Caused by preformed heat-stable enterotoxins (A–E). Rapid onset (1–6 hours): severe nausea, vomiting, diarrhoea. Self-limited; no fever or systemic signs.	🥤 Supportive only: Oral or IV rehydration and electrolyte replacement. 🚫 No antibiotics: Toxin-mediated, not active bacterial infection. 🥗 Prevention: Proper food refrigeration (<4°C), hand hygiene, avoid cross-contamination.

References (Key Sources – 2026)

Liu C, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children. Clin Infect Dis. 2011;52(3):e18–e55. (Primary MRSA reference)
IDSA Staphylococcus aureus (MSSA) Bacteremia Measure Set (Updated January 2025). Available at IDSA website.
Stevens DL, et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10–e52.
CDC. Toxic Shock Syndrome (Other Than Streptococcal) (TSS) – 2011 Case Definition & Clinical Guidance (updated 2025). cdc.gov/tss
Baddour LM, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications (AHA 2015). Circulation. 2015;132(15):1435–1486. (2026 joint IDSA/ESCMID S. aureus bacteremia guideline draft available for comment).
PIDS/IDSA Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics (2021). J Pediatric Infect Dis Soc.

This is an educational review only. Always consult current institutional protocols, local antibiograms, and specialist input. Last updated: March 2026.

```

The content on this website is provided for educational and informational purposes only to support exam preparation (e.g., MLA, MRCP, USMLE) and learning. This is NOT medical advice, diagnosis, treatment, or professional guidance. It does not replace consultation with a qualified healthcare professional, official guidelines (e.g., NICE, GMC, BNF), or supervised clinical practice. Always verify information with current, authoritative sources. Makindo and its contributors accept no liability for any reliance on this content, including errors, omissions, or any resulting harm, loss, or consequences. By using this site, you agree to these terms.

Staphylococcal Infections

References (Key Sources – 2026)

Categories